Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
RDY — Dr. Reddy's Laboratories Limited
NYSE
FULL STOCK PAGE →

Q4 2026 Earnings Call Summary

MAY 12, 2026
REVENUE
$76.33B -12.5%
NET MARGIN
2.9% -10.9 PTS
EPS
$2.68 -81.6%
FREE CASH FLOW
$10.75B +199.6%

No summary has been written for this call yet.